Fig. 3
From: Decreased level of serum NT-proCNP associates with disease severity in COVID-19
Associations between clinical and laboratory parameters and the composite endpoint (death and/or need for mechanical ventilatory support and/or ECMO) in COVID-19 patients. Scale: log odds difference of the composite endpoint associated with presence vs. absence of categorical predictors, or single-unit (unless indicated otherwise) increase of continuous predictors estimated by simple logistic regression. Markers indicate log odds difference with 95% CI. Some variables were homogenous in the sample (chronic kidney disease, coronary artery disease, heart failure, ACEI, GCS on admission, dyspnoea), confounding by indication (O2 supply) or missing in too many subjects (vWF activity, vWF antigen, fibrinogen), thus are not included in this analysis. ACEI angiotensin-converting enzyme inhibitor, ARB angiotensin receptor blocker, BMI body mass index, CK creatine kinase, CRP C-reactive protein, COVID-19 coronavirus disease 2019, ECMO extracorporeal membrane oxygenation, GGT gamma-glutamyltransferase, GOT glutamic oxaloacetic transaminase, GPT glutamic pyruvic transaminase, IL-6 interleukin 6, LDH lactate dehydrogenase, NT-proBNP amino terminal pro-brain natriuretic peptide, NT-proCNP amino terminal pro-C-type natriuretic peptide, PCT procalcitonin